Skip to main content

Want a detailed portfolio tracker?

Alzamend Neuro (ALZN) P/E (2021 - 2026)

Alzamend Neuro (ALZN) P/E from Jun 15, 2021 to Jul 20, 2026. The TTM Alzamend Neuro (ALZN) P/E is -0.40. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alzamend Neuro (ALZN)

YearP/EChange
2026-0.40-8.10%
2025-0.43-64.87%
2024-1.23-78.26%
2023-5.67-91.15%
2022-64.08-81.13%
2021-339.63N/A

Comparison Alzamend Neuro (ALZN) P/E with competitors

Alzamend Neuro (ALZN) P/E is -0.40.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.43%
NBYStablecoin Development Corp0.00-101.08%
ENLVEnlivex Ltd0.07-118.79%
FGENFibroGen Inc0.24-160.30%
CHRSCoherus Biosciences Inc0.85-313.14%
FBIOFortress Biotech Inc0.95-338.39%
ORMPOramed Pharmaceuticals Inc1.50-477.55%
AGENAgenus Inc3.01-855.98%
INVAInnoviva Inc3.15-892.25%
VXRTVaxart Inc3.55-991.65%
CRMDCorMedix Inc3.63-1011.42%
CVACCureVac N.V.4.45-1216.70%
GLPGGalapagos NV4.86-1320.50%
SRPTSarepta Therapeutics Inc4.88-1326.33%
ABEOAbeona Therapeutics Inc5.39-1453.28%
ABUSArbutus Biopharma Corp5.60-1505.56%
ZVRAZevra Therapeutics Inc5.89-1578.81%
SPROSpero Therapeutics Inc6.23-1664.51%
CGENCompugen Ltd6.31-1685.99%
RIGLRigel Pharmaceuticals6.87-1826.19%
SLXNSilexion Therapeutics Corp7.30-1932.69%
OMEROmeros Corporation9.26-2425.70%
AUPHAurinia Pharmaceuticals Inc9.58-2507.64%
PLXProtalix BioTherapeutics Inc10.89-2835.70%
ACADAcadia Pharmaceuticals Inc11.73-3046.08%
TBPHTheravance Biopharma Inc12.26-3180.12%
ADMAAdma Biologics Inc12.42-3219.31%
HRMYHarmony Biosciences Holdings Inc13.82-3571.49%
SABSSAB Biotherapeutics Inc14.14-3650.87%
NAGENiagen Bioscience Inc14.82-3822.16%
INCYIncyte Corp15.82-4074.46%
REGNRegeneron Pharmaceuticals Inc15.86-4083.03%
PBYIPuma Biotechnology Inc17.32-4449.53%
CPRXCatalyst Pharmaceuticals Inc17.44-4480.57%
EXELExelixis Inc17.54-4505.37%
TGTXTG Therapeutics Inc18.97-4864.08%
MDXGMimedx Group Inc20.55-5262.58%
XOMAXOMA Royalty Corp22.87-5846.04%
ARGXArgen X SE24.30-6203.57%
CTMXCytomX Therapeutics Inc24.82-6334.97%
XOMAOXOMA Royalty Corp25.34-6466.52%
HALOHalozyme Therapeutics Inc25.62-6536.58%
XOMAPXOMA Royalty Corp25.67-6548.24%
VRTXVertex Pharmaceuticals Inc27.99-7132.17%
RPRXRoyalty Pharma plc - Class A28.69-7306.20%
SLNOSoleno Therapeutics Inc29.02-7388.55%
ASNDAscendis Pharma A/S30.09-7657.38%
LGNDLigand Pharmaceuticals Inc - Class B37.91-9623.36%
APLSApellis Pharmaceuticals Inc39.02-9901.99%
BMRNBiomarin Pharmaceutical Inc42.21-10703.46%
KRYSKrystal Biotech Inc45.34-11490.11%
ONCBeiGene Ltd69.54-17568.31%
PHARPharming Group N.V.75.03-18946.16%
TECHBio-Techne Corp101.96-25711.59%
VCELVericel Corp109.92-27711.85%
ALNYAlnylam Pharmaceuticals Inc117.96-29732.42%
GMABGenmab140.29-35340.55%
TLXTelix Pharmaceuticals Ltd162.15-40832.22%
CORTCorcept Therapeutics Inc212.86-53569.06%